Related Experiment Video
Updated: Aug 6, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.2K
Novel breakthroughs in advanced prostate cancer management
Eddy Lilly1, Julien Sarkis1, Omar Mahmoud2
1Urology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
Expert Review of Anticancer Therapy
|March 23, 2023
Summary
This review covers novel prostate cancer therapies, emphasizing biomarkers for personalized medicine. It highlights advanced treatments like radiotherapy, androgen deprivation therapy, PARP inhibitors, and immunotherapy for improved patient outcomes.
Area of Science:
- Oncology
- Urology
Background:
- Prostate cancer remains the most common cancer in men, necessitating advanced treatment strategies.
- Biomarkers are crucial for stratifying patients and personalizing prostate cancer treatment.
Purpose of the Study:
- To provide a pragmatic review of novel prostate cancer therapies.
- To guide clinicians in selecting optimal treatments for patients.
Main Methods:
- Comprehensive review of the medical literature on prostate cancer treatments.
- Analysis of approved and investigational therapeutic agents.
Main Results:
- Local radiotherapy is effective for low-burden metastatic prostate cancer.
- Androgen deprivation therapy remains a cornerstone treatment, with efforts to delay resistance being critical.
- For metastatic castrate-resistant prostate cancer, PARP inhibitors, N-terminal domain inhibitors, and immunotherapy offer new therapeutic avenues.
Conclusions:
- Personalized medicine approaches utilizing biomarkers are essential for effective prostate cancer management.
- Novel therapeutic combinations, including PARP inhibitors and immunotherapy, show promise for advanced disease.
Keywords:
BiomarkersImmunotherapyNivolumabOlaparibPARP inhibitorsProstate cancerRucaparibTargeted radionuclide therapyMore Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:30Cancer Vaccines
460
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
460
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K